Click Here for 5% Off Your First Aladdin Purchase!

TCMDC-135051 , CAS No.T614355, Plasmodium falciparum cyclin-dependent-like kinase CLK3

  • Moligand™
Item Number
T614355
Grouped product items
SKUSizeAvailabilityPrice Qty
T614355-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$317.90
T614355-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$950.90

Basic Description

GradeMoligand™
Mechanism of actionPlasmodium falciparum cyclin-dependent-like kinase CLK3

Associated Targets

CLK3 Tchem Dual specificity protein kinase CLK3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[2-[3-(diethylaminomethyl)-2-methoxyphenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-2-propan-2-ylbenzoic acid
INCHI InChI=1S/C29H33N3O3/c1-6-32(7-2)17-20-9-8-10-23(27(20)35-5)26-16-25-21(13-14-30-28(25)31-26)19-11-12-22(29(33)34)24(15-19)18(3)4/h8-16,18H,6-7,17H2,1-5H3,(H,30,31)(H,33,34)
InChi Key LVVFYPXMXIDWRP-UHFFFAOYSA-N
Canonical SMILES CCN(Cc1cccc(c1OC)c1cc2c([nH]1)nccc2c1ccc(c(c1)C(C)C)C(=O)O)CC
Isomeric SMILES CCN(CC)CC1=C(C(=CC=C1)C2=CC3=C(C=CN=C3N2)C4=CC(=C(C=C4)C(=O)O)C(C)C)OC
PubChem CID 44528327

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Mahindra A, Janha O, Mapesa K, Sanchez-Azqueta A, Alam MM, Amambua-Ngwa A, Nwakanma DC, Tobin AB, Jamieson AG.  (2020)  Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials..  J Med Chem,  63  (17): (9300-9315).  [PMID:32787140]
2. Alam MM, Sanchez-Azqueta A, Janha O, Flannery EL, Mahindra A, Mapesa K, Char AB, Sriranganadane D, Brancucci NMB, Antonova-Koch Y et al..  (2019)  Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target..  Science,  365  (6456): (589-97).  [PMID:31467193]

Solution Calculators